I
ZOM

INVST’s Zomedica Corp. ZOM Stock Holding History

INVST’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,306
Closed -$7.84K – 343
2024
Q4 		$7.84K Hold
65,306
– – ﹤0.01% 248
2024
Q3 		$8.96K Sell
65,306
-2,500
-4% -$351 ﹤0.01% 254
2024
Q2 		$9.96K Sell
67,806
-175
-0.3% -$26 ﹤0.01% 265
2024
Q1 		$9.52K Hold
67,981
– – ﹤0.01% 240
2023
Q4 		$8.92K Hold
67,981
– – ﹤0.01% 216
2023
Q3 		$11.4K Hold
67,981
– – ﹤0.01% 189
2023
Q2 		$13.6K Hold
67,981
– – ﹤0.01% 179
2023
Q1 		$13.8K Buy
67,981
+1,000
+1% +$245 ﹤0.01% 162
2022
Q4 		$18.5K Hold
66,981
– – ﹤0.01% 165
2022
Q3 		$13K Hold
66,981
– – ﹤0.01% 171
2022
Q2 		$26K Hold
66,981
– – ﹤0.01% 180
2022
Q1 		$14K Hold
66,981
– – ﹤0.01% 187
2021
Q4 		$22K Buy
66,981
+30,516
+84% +$13.7K ﹤0.01% 181
2021
Q3 		$19K Buy
+36,465
New +$21.5K ﹤0.01% 195

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

INVST's ZOM Position: Q1 2025 in Review

INVST sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 65,306 shares — an estimated $7.84K sold.

INVST first reported a position in ZOM in Q3 2021 and held it in 14 quarters. The position peaked at $26K in Q2 2022. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • INVST reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • INVST sold 65,306 Zomedica Corp. shares in Q1 2025, an estimated $7.84K.
  • INVST first reported a position in Zomedica Corp. in Q3 2021 and held it in 14 quarters.
  • INVST's Zomedica Corp. position peaked at $26K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on INVST's 13F filing for Q1 2025, filed 3 Jun 2025.